SCHEMBL13445248

SCHEMBL13445248

N#Cc1cccc(C(=O)N2CCC(c3cn(Cc4ccccc4)c4ccccc34)CC2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMO Q99835 1/20 0.57
HTR2A P28223 2/20 0.53
HTR2C P28335 2/20 0.53
HTR2B P41595 2/20 0.53
HRH2 P25021 7/20 0.51
SLC2A1 P11166 1/20 0.51
DRD2 P14416 1/20 0.49
HTR6 P50406 1/20 0.49
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
SLC9A1 P19634 1/20 0.47
CYP2C19 P33261 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SLC5A1 P13866 1/20 0.45
SLC5A2 P31639 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
KDM1A O60341 1/20 0.44
CNR2 P34972 1/20 0.44
RORC P51449 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3599338 0.93 SLC2A1 (0.55) SMOHTR2AHTR2CHTR2BHRH2
SCHEMBL20431419 0.89 HTR2A (0.51) SMOHTR2AHTR2CHTR2BHRH2
SCHEMBL14084478 0.86 HTR2A (0.55) SMOHTR2AHTR2CHTR2BHRH2
SCHEMBL3598410 0.83 SMO (0.54) SMOSLC2A1DRD2HTR6CYP3A4
SCHEMBL3615414 0.81 SLC2A1 (0.64) HTR2AHTR2CHTR2BHRH2SLC2A1
SCHEMBL5202596 0.81 ALDH1A1 (0.47) SMOHTR2AHTR2CHTR2BHRH2
SCHEMBL20431459 0.79 SLC2A1 (0.57) HTR2AHTR2CHTR2BHRH2SLC2A1
SCHEMBL5201634 0.78 SLC2A1 (0.47) SMOHTR2AHTR2CHTR2BHRH2
SCHEMBL4859724 0.78 SMO (0.46) SMOHTR2AHTR2CHTR2BHRH2
SCHEMBL3598394 0.78 SIGMAR1 (0.57) SMOHTR2AHTR2CHTR2BHRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137162-B1 ORGANIC COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2018-08-01 EP disclosed
US-8536168-B2 Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway NOVARTIS AG (CH) 2013-09-17 US disclosed
US-8536168-B2 Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway NOVARTIS AG (CH) 2013-09-17 US disclosed
US-20100069368-A1 Organic Compounds and Their Uses NOVARTIS AG (CH) 2010-03-18 US disclosed
US-20100069368-A1 Organic Compounds and Their Uses NOVARTIS AG (CH) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069368-A1 Organic Compounds and Their Uses SHH, GLI1, VHL SMO 5/4885HTR2A 4363/4885HTR2C 3578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.